About the role
The promise of crypto is to upgrade the very foundations of our society – from money, finance, and governance to media, gaming, and science. To deliver on that promise, decentralized technologies are to be integrated into the everyday experiences of billions of people. For engineering, this is a mountain of a challenge.
Eiger was founded to develop infrastructure for blockchain mass adoption. We help technology companies improve and integrate the core technologies of crypto to meet the climbing demands for scale and performance.
We currently employ senior blockchain engineers across the globe and work with some of the most ambitious organizations in the industry, including Celestia, Polkadot, Stellar, Zcash, Axelar, Avail, Internet Computer, Aleo, Starknet, Fireblocks, XRP Labs, Solana, Aptos, zkSync to name a few.
If you're interested in hearing about new opportunities, you can drop your CV, GitHub or LinkedIn.
Salary & benefits:
Salary and benefits will be negotiated separately based on the candidate’s skills and experience. Please note that we hire our international talent residing outside of Finland with contractor status, this means that you'd be invoicing us every month and paying your own social security contributions.
More about the company:
Read more about our vision and projects on our website eiger.co and explore our open-source work on GitHub.
Please check your spam/junk folder after applying, as our confirmation email and future emails throughout the application process may end up there!
We look forward to meeting you!
Your application may be processed by EQG or its subsidiaries, and may also be considered for other suitable roles within the group.
Aplyr's read
Eiger is a biotechnology firm dedicated to creating therapies for rare genetic disorders, attracting professionals passionate about innovative medical solutions.
What's promising
- •Eiger focuses on niche markets with high unmet medical needs, offering growth potential.
- •Strong pipeline of therapies targeting rare genetic disorders.
- •Collaborative work culture encourages innovation and cross-disciplinary learning.
What to watch
- •High risk due to reliance on successful clinical trials.
- •Limited public information about financial stability.
- •Intense competition in the biotechnology sector for rare disease therapies.
Why Eiger
- •Specializes in therapies for rare genetic disorders, a less crowded market.
- •Emphasizes rapid development cycles to address urgent medical needs.
- •Engages in strategic partnerships to enhance research and development capabilities.
Aplyr’s read is generated by AI from public sources. Was it useful?
About Eiger
Eiger is a biotechnology company focused on developing therapies for rare diseases, particularly those related to genetic disorders.
